Check Out What Whales Are Doing With ABBV
Portfolio Pulse from Benzinga Insights
A significant bearish stance has been taken on AbbVie (NYSE:ABBV) by a large investor, as indicated by unusual options activity. The sentiment among these big-money traders is 30% bullish and 70% bearish. The whales have been targeting a price range from $115.0 to $165.0 for AbbVie over the last 3 months. HSBC and Morgan Stanley have downgraded their actions on AbbVie to Buy and Overweight respectively, with price targets of $167 and $182.
July 20, 2023 | 4:32 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
A large investor has taken a bearish stance on AbbVie, with unusual options activity indicating a price target range of $115.0 to $165.0. HSBC and Morgan Stanley have downgraded their actions on the stock.
The bearish stance taken by a large investor, as indicated by unusual options activity, combined with the downgrades by HSBC and Morgan Stanley, could potentially lead to a short-term decrease in AbbVie's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100